Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer-Reference-Cited by-同舟云学术

Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer

Published:2016-02-04 Issue:10 Volume:7 Page:11412-11423
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yang Hee Doo¹²,Kim Pum-Joon³,Eun Jung Woo¹²,Shen Qingyu¹²,Kim Hyung Seok¹²,Shin Woo Chan¹²,Ahn Young Min⁴,Park Won Sang¹,Lee Jung Young¹,Nam Suk Woo¹²⁵

Affiliation:

1. Laboratory of Oncogenomics, Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea

2. Functional RNomics Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea

3. Department of Cardiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea

4. Department of Kidney System, College of Oriental Medicine, Kyung Hee University, Seoul 02447, Republic of Korea

5. Cancer Evolution Research Center, The Catholic University of Korea, Seoul 06591, Republic of Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of cellular heterogeneity in recurrent pediatric glioblastoma: Machine learning-enhanced single-cell RNA-Seq unveils regulatory signatures;Human Gene;2024-09

2. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment;PLOS ONE;2024-04-18

3. Roles of Histone H2A Variants in Cancer Development, Prognosis, and Treatment;International Journal of Molecular Sciences;2024-03-09

4. Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells;Cells;2024-01-02

5. Isoliquiritigenin suppresses the progression of malignant melanoma via targeting H2A.Z.1-E2F1 pathway;Biochemical Pharmacology;2023-12